Table 1. Time x group interaction p-values from generalized estimating (GEE) and linear mixed effect models (LMM).
Outcome measures | Mietus-Snyder et al. GEE. | Corrected GEEa | LMM v1 (without clustering/ nesting)b | LMM v2 (with clustering/ nesting)c | Comparing LMM v1 to LMM v2; Significance in both, neither, or changedd | |
---|---|---|---|---|---|---|
Using p<0.05 | Using p≤0.002 | |||||
Fasting plasma ceramides | ||||||
Cer C14:0 | 0.007 | 0.007 | 0.013 | 0.018 | Both | Neither |
Cer C16:0 | 0.024 | 0.024 | 0.029 | 0.035 | Both | Neither |
Cer C18:0 | 0.192 | 0.192 | 0.229 | 0.236 | Neither | Neither |
Cer C18:1 | 0.058 | 0.058 | 0.080 | 0.088 | Neither | Neither |
Cer C20:0 | 0.045 | 0.045 | 0.060 | 0.068 | Neither | Neither |
Cer C20:1 | 0.325 | 0.259 | 0.274 | 0.281 | Neither | Neither |
Cer C22:0 | 0.040 | 0.040 | 0.055 | 0.063 | Neither | Neither |
Cer C22:1 | 0.117 | 0.111 | 0.125 | 0.134 | Neither | Neither |
Cer C24:0 | 0.356 | 0.352 | 0.341 | 0.348 | Neither | Neither |
Cer C24:1 | 0.014 | 0.014 | 0.023 | 0.029 | Both | Neither |
T. Cer | 0.144 | 0.144 | 0.147 | 0.155 | Neither | Neither |
Plasma sphingolipid bases | ||||||
Sphinganine e | p≤0.002 (reported in the text) | 0.007 | 0.013 | 0.017 | Both | Neither |
Sphingosine | 0.02 | 0.503 | 0.573 | 0.577 | Neither | Neither |
Dihydro-sphingosine-1-phosphate | 0.05 | 0.488 | 0.492 | 0.490 | Neither | Neither |
Sphingosine -1-phosphate | 0.007 | 0.522 | 0.549 | 0.553 | Neither | Neither |
Plasma amino acid metabolites | ||||||
Arginine e | - | 0.041 | 0.065 | 0.074 | Neither | Neither |
Serine | 0.0001 | 0.002 | 0.006 | 0.009 | Both | Neither |
Proline | 0.0001 | <0.001 | <0.001 | <0.001 | Both | Both |
Aspartate | 0.0001 | <0.001 | 0.001 | 0.002 | Both | Both |
Cystathionine | 0.0001 | 0.046 | 0.059 | 0.068 | Neither | Neither |
Sarcosine | 0.0001 | 0.011 | 0.010 | 0.014 | Both | Neither |
Ornithine | 0.001 | 0.178 | 0.222 | 0.222 | Neither | Neither |
Arginine Bioavailability Ratio | 0.001 | <0.001 | 0.002 | 0.003 | Both | Changed |
Lysine | 0.002 | 0.051 | 0.061 | 0.070 | Neither | Neither |
Alanine | 0.003 | <0.001 | <0.001 | 0.001 | Both | Both |
Glutamine | 0.007 | 0.087 | 0.108 | 0.115 | Neither | Neither |
Threonine | 0.008 | 0.032 | 0.048 | 0.050 | Changed | Neither |
Methionine | 0.01 | 0.102 | 0.144 | 0.155 | Neither | Neither |
Fischer ratio | 0.01 | 0.576 | 0.548 | 0.537 | Neither | Neither |
Citrulline | 0.02 | 0.005 | 0.014 | 0.019 | Both | Neither |
Histidine | 0.02 | 0.379 | 0.354 | 0.361 | Neither | Neither |
Tryptophan | 0.02 | 0.405 | 0.480 | 0.483 | Neither | Neither |
Leucine | 0.02 | 0.032 | 0.064 | 0.075 | Neither | Neither |
Phenylalanine | 0.03 | 0.082 | 0.115 | 0.125 | Neither | Neither |
Anthropometric and clinical measures d | ||||||
Activity score | - | 0.483 | 0.474 | 0.479 | Neither | Neither |
Vitamin D | p<0.05 in both adolescent and adult subgroups | <0.001 | 0.003 | 0.005 | Both | Neither |
Weight | - | 0.898 | 0.898 | 0.898 | Neither | Neither |
Waist to height ratio | - | 0.137 | 0.162 | 0.172 | Neither | Neither |
BMI | - | 0.672 | 0.674 | 0.677 | Neither | Neither |
Adiponectin | - | 0.551 | 0.597 | 0.601 | Neither | Neither |
HsCRP | - | 0.223 | 0.264 | 0.271 | Neither | Neither |
Glucose | - | 0.421 | 0.430 | 0.435 | Neither | Neither |
Insulin | - | 0.202 | 0.234 | 0.242 | Neither | Neither |
Homeostatic model assessment of insulin resistance | - | 0.287 | 0.310 | 0.317 | Neither | Neither |
Plasma total cholesterol | - | 0.110 | 0.134 | 0.143 | Neither | Neither |
Plasma triglyceride | - | 0.416 | 0.450 | 0.455 | Neither | Neither |
LDL | - | 0.222 | 0.241 | 0.248 | Neither | Neither |
HDL | - | 0.259 | 0.302 | 0.309 | Neither | Neither |
Systolic blood pressure | p<0.05 in adolescent subgroup | 0.058 | 0.083 | 0.092 | Neither | Neither |
Diastolic blood pressure | - | 0.235 | 0.272 | 0.281 | Neither | Neither |
Resting heart rate | - | 0.106 | 0.136 | 0.146 | Neither | Neither |
a These p-values represent revised values of the incorrect report in The Article after discussions with the authors. These p-values are thus calculated with the model used by Mietus-Snyder et al. that ignores household clustering.
b This model still ignores household clustering and nesting.
c Including random intercepts for household units and adjusted degrees of freedom using between-within method.
d Comparing LMM models with and without clustering and nesting effects being accounted for. We note both <0.05 and ≤0.002 thresholds per the authors’ intention to use them for different outcomes. Because they were used inconsistently in the text, we report here the consequences for both.
e Exact p-values for Arginine, Sphinganine, and anthropometric and clinical measures were not reported in The Article.